The DIRAZEC brand, founded in 2008 (United States), from
126 sister brands
and 17477 competing brands.
The DIRAZEC brand is owned by Celgene, a company listed in New York.
The sector of DIRAZEC is Drug Manufacturers.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.